CVS Health Files 8-K: Other Events & Financials

Ticker: CVS · Form: 8-K · Filed: 2024-12-06T00:00:00.000Z

Sentiment: neutral

Topics: sec-filing, 8-k, financials

Related Tickers: CVS

TL;DR

CVS filed an 8-K on Dec 6th for other events and financials - check for updates.

AI Summary

CVS Health Corporation filed an 8-K on December 6, 2024, reporting other events and financial statements. The filing does not contain specific details on new transactions or financial figures but serves as a notification of these items being filed.

Why It Matters

This filing indicates that CVS Health has submitted important updates regarding its operations and financial status to the SEC, which could contain material information for investors.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of events and financial statements without immediate, specific negative or positive news.

Key Players & Entities

FAQ

What specific 'Other Events' are being reported by CVS Health in this 8-K filing?

The provided text does not detail the specific 'Other Events' beyond stating that this item is being reported.

Are there any new financial statements or exhibits attached to this 8-K filing?

The filing indicates that 'Financial Statements and Exhibits' are being reported, but the content of these is not specified in the provided text.

What is the significance of the 'Conformed Period of Report' being December 6, 2024?

This date signifies the period to which the reported information in the 8-K filing pertains.

Does this 8-K filing announce any material changes to CVS Health's business or financial condition?

The filing is categorized under 'Other Events' and 'Financial Statements and Exhibits,' suggesting potential material information, but the specific nature of these events is not detailed in the provided excerpt.

What was CVS Health's former company name and when did the name change occur?

CVS Health Corporation was formerly known as CVS CAREMARK CORP (name change on 20070509) and CVS/CAREMARK CORP (name change on 20070322), and prior to that, CVS CORP (name change on 19970128).

From the Filing

0001193125-24-272437.txt : 20241206 0001193125-24-272437.hdr.sgml : 20241206 20241206160101 ACCESSION NUMBER: 0001193125-24-272437 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20241206 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20241206 DATE AS OF CHANGE: 20241206 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CVS HEALTH Corp CENTRAL INDEX KEY: 0000064803 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 050494040 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-01011 FILM NUMBER: 241532190 BUSINESS ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 BUSINESS PHONE: 4017651500 MAIL ADDRESS: STREET 1: ONE CVS DR. CITY: WOONSOCKET STATE: RI ZIP: 02895 FORMER COMPANY: FORMER CONFORMED NAME: CVS CAREMARK CORP DATE OF NAME CHANGE: 20070509 FORMER COMPANY: FORMER CONFORMED NAME: CVS/CAREMARK CORP DATE OF NAME CHANGE: 20070322 FORMER COMPANY: FORMER CONFORMED NAME: CVS CORP DATE OF NAME CHANGE: 19970128 8-K 1 d641657d8k.htm 8-K 8-K CVS HEALTH Corp false 0000064803 0000064803 2024-12-06 2024-12-06     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 6, 2024       CVS HEALTH CORPORATION (Exact name of registrant as specified in its charter)       Delaware   001-01011   05-0494040 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.)   One CVS Drive , Woonsocket , Rhode Island   02895 (Address of principal executive offices)   (Zip Code) Registrant’s telephone number, including area code: (401) 765-1500 Former name or former address, if changed since last report: N/A     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, par value $0.01 per share   CVS   New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company  ☐         If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Section 8 - Other Events   Item 8.01 Other Events. On December 6, 2024, CVS Health Corporation, a Delaware corporation (the “Company”), issued a press release announcing the pricing of its cash tender offer for any and all of its 4.100% Senior Notes due 2025, in connection with the Company’s previously announced cash tender offers commenced on December&#1

View on Read The Filing